Scientific and Medical Equipment House Company

4014.SRSAUHealthcare● Active

$31.50

$-0.10(-0.32%)

Market Cap$945000000

P/E Ratio—

52W High$41

52W Low$26

Avg Volume58K

Open$31.70

Beta0.14

Free Cash Flow Financials Revenue

Scientific and Medical Equipment House Company (4014.SR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

4014.SR · free cash flow · updated Jun 15, 2026

Core FCF metrics

4014.SR · FCF · TTM · margin & CAGR

Free cash flow was −$12.8M for FY2025 (fiscal year ending 2025-12-31), down 104.5% year-over-year The FCF margin was -1.5%.

FY2025 Free Cash Flow−$12.8M▼ -104.5% YoY

Trailing 12M (TTM)−$10.6Mtrailing 4 quarters sum

FCF Margin-1.5%−$12.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

4014.SR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$5.7M(7M)−$12.8M▼ 104.5%-1.5%

FY2024$285.8M(4M)$285.8M▲ +283.8%32.6%

FY2023−$140.6M(15M)−$155.5M▼ 246.4%-19.5%

FY2022$124.0M(18M)$106.2M▲ +215.2%14.9%

FY2021−$84.7M(7M)−$92.2M▼ 197.7%-13.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

4014.SR · P/FCF · FCF yield · FCF per share

Scientific and Medical Equipment House Company (4014.SR) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

4014.SR · cash flow statement · operating / investing / financing

For FY2025, Scientific and Medical Equipment House Company generated −$5.7M in operating cash flow and spent 7M in capital expenditures, yielding −$12.8M in free cash flow.

Operating Activities

−$5.7M

Cash from core business operations

2025-12-31

Investing Activities

−$7.3M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$54.6M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$5.7M) − |CapEx| (7M) = FCF (−$12.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

4014.SR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Scientific and Medical Equipment House CompanyYOU

4014.SR

−$12.8M-104.5%-1.5%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Scientific and Medical Equipment House Company (4014.SR) reported free cash flow of −$12.8M for FY2025 (fiscal year ending 2025-12-31), down 104.5% year-over-year. The FCF margin was -1.5%.

Based on available data, Scientific and Medical Equipment House Company has maintained positive free cash flow for at least 5 fiscal year(s). FCF peaked at $285.8M in FY2024.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

4014.SR free cash flow · 8 questions

Scientific and Medical Equipment House Company free cash flow was −$12.8M for FY2025, down 104.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$10.6M.

4014.SR free cash flow4014.SR FCF4014.SR FCF 20254014.SR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Scientific and Medical Equipment House Company · Scientific and Medical Equipment House Company SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026